© The Board of Management and Trustees of the British Journal of Anaesthesia 2005. All rights reserved. For Permissions, please e-mail: journal.permissions@oupjournals.org
CORRESPONDENCE |
Moles, weights and potencies: freedom of expression!
* E-mail: g.a.mcleod@dundee.ac.uk
| The first 10% of the full text of this article appears below. |
EditorRosenberg and Schug correctly remind us that there are 12.6% more molecules of bupivacaine in similarly expressed %wt/vol preparations of levobupivacaine (Chirocaine®) when compared with the racemate.1 They also correctly acknowledge that this difference was first highlighted in the British Journal of Anaesthesia in 1998.2 In that paper, the issue of regulatory changes to
1 Dundee, UK
2 Manchester, UK
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. F. Luck, P. D. W. Fettes, and J. A. W. Wildsmith Spinal anaesthesia for elective surgery: a comparison of hyperbaric solutions of racemic bupivacaine, levobupivacaine, and ropivacaine Br. J. Anaesth., November 1, 2008; 101(5): 705 - 710. [Abstract] [Full Text] [PDF] |
||||
